Full Text HD-97-010 DATA COORDINATING CENTER for the COOPERATIVE MULTICENTER NEONATAL RESEARCH NETWORK NIH GUIDE, Volume 26, Number 23, July 18, 1997 RFA: HD-97-010 P.T. 34 Keywords: Data Management/Analysis+ Clinical Trial National Institute of Child Health and Human Development Letter of Intent Receipt Date: August 1,1997 Application Receipt Date: September 19, 1997 PURPOSE The National Institute of Child Health and Human Development (NICHD) is interested in clinical research in neonatal medicine and supports an ongoing 14-center Neonatal Research Network to do clinical research to investigate the safety and efficacy of treatment and management strategies to care for newborn infants, particularly those of low birth weight. The Network is funded by cooperative agreements and includes a Data Center which provides statistical expertise, data management, and analysis for Network trials and studies. The current Data Center has been the Network Data Center since its inception and is supported through March 31, 1998. NICHD invites all potential applicants to apply for the cooperative agreement to participate as the Data Center for the NICHD Neonatal Research Network. The successful applicant will be responsible for completing ongoing trials and studies and initiating new research in neonatology and perinatology. HEALTHY PEOPLE 2000 The Public Health Service (PHS) is committed to achieving the health promotion and disease prevention objectives of "Healthy People 2000," a PHS-led national activity for setting priority areas. This Request for Application (RFA), Cooperative Multicenter Neonatal Research Network, is related to the priority area of low birth weight. Potential applicants may obtain a copy of "Healthy People 2000" (Full Report: Stock No. 017-001-00474-0) or "Healthy People 2000" (Summary Report: Stock No. 017-001-00473-1) through the Superintendent of Documents, Government Printing Office, Washington, DC 20402-9325 (telephone 202-512-1800). ELIGIBILITY REQUIREMENTS Applications may be submitted by domestic organizations, public and private, such as universities, colleges, hospitals, laboratories, units of State and local governments, and eligible agencies of the Federal government. Racial/ethnic minority individuals, women, and persons with disabilities are encouraged to apply as Principal Investigators. Organizations should have experience in functioning as a statistical coordinating center for multi-center research, including randomized controlled trials and observational studies of both a medical (preferable neonatal and perinatal) and a psychological nature. The need for continuous and active communication among sites and with the NICHD dictates that only U.S. institutions with a branch or central office in the Washington, DC metropolitan area are eligible to apply. MECHANISM OF SUPPORT The administrative and funding instrument to be used for this program will be a cooperative agreement (U01), an "assistance" mechanism (rather than an "acquisition" mechanism), in which substantial NIH scientific and/or programmatic involvement with the awardee is anticipated during performance of the activity. Under the cooperative agreement, the NIH purpose is to support and stimulate the recipients' activity by involvement in the activity and otherwise working jointly with the award recipients in a partnership role. Details of the responsibilities, relationships and governance of the study to be funded under cooperative agreements are discussed later in this document under the section "Terms and Conditions of Award." The total project period for applications submitted in response to the present RFA may not exceed five years. The anticipated award date is April 1, 1998. NICHD intends that the ongoing Cooperative Agreements will be recompeted every five years, depending on available funds. FUNDS AVAILABLE It is anticipated that one award for a Data Center will be made, with an estimated total cost of $2 million (including direct and facilities and administrative costs) in the first year. Although this program is provided for in the financial plans of the NICHD, awards pursuant to this RFA are contingent upon the availability of funds for this purpose. RESEARCH OBJECTIVES A. Backrgound Modern neonatology medicine has introduced a number of principles of management and innovative methodologies without rigorous use of the controlled observation necessary for their objective evaluation. A major problem has been the balance between assuring prompt implementation of new technologies, procedures, treatments and drugs, and adequate evaluation of their safety and efficacy. Indeed, because of the urgent demands of sick infants, care is often based on limited knowledge of new modalities not subjected to critical studies prior to their introduction and use. In a critically-ill infant, an innovative idea may be tried which, if the infant's condition improved, may rapidly set a new trend, and become the standard of care. Therefore, their incorporation into the arsenal of therapies frequently is based on limited experience, and their efficacy and/or safety have not been evaluated scientifically. In an attempt to respond to the need for well-designed clinical trials in neonatal medicine, NICHD established a Neonatal Research Network and a companion Maternal Fetal Medicine Unit Network in 1986. The first Network consisted of seven clinical centers; in 1991 the membership was expanded to 12 and capitation funding of multiple simultaneous trials and studies was introduced. In the latest recompetition (RFA 95-HD-06) two new centers were added. Among the areas addressed by the Network are trials of therapies for sepsis, intraventricular hemorrhage, chronic lung disease, pulmonary hypertension, and studies of the impact of drug exposure on child and family outcome, and a standardized follow-up program of extremely low birth weight (ELBW, < 1000 gms) infants. In addition, the Network supports a registry of infants less than 1500 grams at birth. Currently, the Network is participating in three trials (indomethacin in the prevention of neurologic disability, supplemental oxygen to prevent retinopathy of prematurity, and vitamin A to prevent lung disease) and four studies: follow up of ELBW infants, intrauterine drug exposure and child and family outcome (Maternal Life Style [MLS] Study), antenatal magnesium sulfate and cerebral palsy, and vitamin A and retinopathy of prematurity. Of these, the follow up and the MLS studies are expected to continue into FY98. Over 8,600 evaluations have been conducted in the MLS study to date. New protocols which are expected to continue into FY98 include a trial of ventilator management and early steroid treatment. Additional areas of interest include all major areas of newborn pathophysiology: cerebral function, pulmonary physiology, gastrointestinal function and nutrition, immunology; the rapid transfer of new technologies to neonatal medicine, and strategies to reduce the cost and preserve the quality of neonatal care. B. Objectives and Scope The awardee is expected to cooperate with the clinical investigators at the 14 Network Clinical Centers, and with the Program Officer and other participating NICHD staff in the design and conduct of protocols, analysis of data, and reporting of results of Network research. Systems for data collection, analysis, coordination, and quality assurance are essential. Required data summaries will be provided to the Network Steering Committee, the subcommittees, NICHD, the Data Safety and Monitoring Committee, and others as determined by the Steering Committee. Logistical services, including provision of study drugs, collecting and storing of biological fluids, and other supplies for the conduct of research may be required. Content of Application The application should have (1) an introduction, either (2a) a progress report (incumbent Data Center grantee only) or, (2b) a description of relevant capabilities and experience (other applicants) and (3a/3b) a research plan for the next competitive segment. The progress report/description and the research plan must incorporate the following minimum requirements: Minimum Requirements for the Data Coordinating Center o Staff must be prepared to cooperate effectively in all Network functions with NICHD and the clinical centers. o The Data Center must have their central or a branch office located in the Washington, DC metropolitan area. o The Data Center must demonstrate prior experience as a data coordinating center in multicenter studies in neonatology/perinatology during the previous five years. o The Principal Investigator, and other staff, must have appropriate expertise and capability in biostatistics, data management, data analysis, and project management. o The Principal Investigator must possess a doctoral degree in an appropriate field and be willing to be committed to at least 90% effort on Network activities. o The Data Center must have the ability to assist in designing protocols, data collection forms, manuals of operation, and data collection systems, including distributed data entry. o The Data Center must have experience in developing and maintaining data quality control systems. o The Data Center must have the capacity to generate monthly reports on subject enrollment for several concurrent studies; quarterly reports on enrollment and clinical center performance (including efforts to reallocate study resources); appropriate reports for the use of the Network Data Safety and Monitoring Committee meetings; and special reports as required below. o The Data Center must demonstrate successful experience in assisting clinical investigators in preparing manuscripts for publication. o The Data Center must have experience in arranging logistical services for multicenter clinical trials, i.e., assuring the appropriate preparation and delivery of study medications to the Clinical Centers. o The Data Center must provide evidence of superior management capability (a) to estimate appropriate and reasonable resources needed for individual projects in its role as the Data Center for multicenter research, (b) to manage those resources efficiently during the research, (c) to adjust the assigned resources as the work changes qualitatively and quantitatively during the research, and (d) to report these resource allocations to NICHD periodically, and (e) to sub-contract with outside organizations to supplement its own resources, as needed. (2a) Progress Report (incumbent center only) o Describe how the Data Center has cooperated effectively in all Neonatal Research Network functions with the NICHD and the Clinical Centers. o Describe the facility and how it has been used for Neonatal Network functions. o Describe how staff strengths in biostatistics, data management, data analysis, and project management have been used in Neonatal Network activities. o Describe the commitment of the Principal Investigator during the previous grant period. o Describe changes in staff and staff assignment during the previous grant period. o Describe processes used in assisting protocol design, data forms preparation, manual preparation, and in data collection for the Network. o Describe the performance in data quality control for the Network. o Describe the generation of data and performance reports on Network Clinical Center activities (include dates of study initiation, termination, final report distribution). o Describe contribution to the preparation of manuscripts from Network studies. o Describe logistical service arrangements for Network protocols. o Describe the organizational systems used to assign and adjust resources to specific protocols of the Network during the previous grant period. o Illustrate the calculation of costs of all Data Center work for the performance of the Dexamethasone trial. (2b) Description of Capabilities and Experience (new applicants only) o Describe previous successful collaboration in multicenter research in neonatology/perinatology within the last five years. o Describe the applicant's facility and how it has been used for multicenter clinical research. o Describe how the Data Center staff's strengths in biostatistics, data management, data analysis, and project management have been used in multicenter clinical research. o Describe the extent of commitment of the Data Center Principal Investigator to this multicenter clinical research. o Describe the processes used in assisting protocol design, forms and manual preparation, and in data collection for previous multicenter clinical research. o Describe the processes used in data quality control in previous multicenter clinical research by the Data Center applicant. o Describe the reports prepared by the applicant on data and performance of Clinical Centers in previous multicenter clinical research. o Summarize the applicant's contributions in preparing manuscripts from previous multicenter clinical research. o Describe logistical services arranged by the applicant in support of multicenter clinical research. o Describe the organizational systems used by the applicant to assign and adjust its resources to participate in multicenter clinical research. o Illustrate the calculation of costs of the applicant's contribution to the performance of a specific clinical protocol conducted in a multicenter setting during the past five years. The sample size, quantity of data accumulated and analyzed, and the number of publications should be specified. (3a) Research Plan for the next competitive segment for the incumbent applicant. o Statement of intent to collaborate in a manner consistent with the terms of the award. o Plans and estimated timetables for all ongoing and planned Network protocols (include the Registry, Magnesium Sulfate, Followup, and Maternal Lifestyles, Vitamin A, Combined Early Steroids and Gentle Ventilation, and Erythropoietin) to be completed, the data analyzed, the results published, and the data archived. o Plans for staff allocation to meet the demands of the plans and timetables in above. o Describe any planned modifications in the Data Center processes to be used in protocol design, data forms preparation, data collection, data quality control, report generation, manuscript preparation, and provision of logical services for the Neonatal Network. o Propose methods to be used to facilitate communication between Data Center staff and other components of the Neonatal Network, including NICHD and the 14 Clinical Centers. o Describe any planned modifications in the organizational systems to assign and adjust resource allocation during protocol performance. This should include any potential for outsourcing to increase efficiency or to meet short-term needs. o Describe new procedures to increase operational efficiency and decrease costs. Include proposals for an expanded role for Clinical Center staff (including statisticians) and strategies to achieve interactive, timely data analysis in collaboration with members of the Steering Committee, while protecting the integrity of the data and the quality of the analyses. o Assume that three new protocols, including two randomized clinical trials and one observational study, were planned but not yet implemented by the Network Data Center applicant. Assume, however, for this exercise that the three studies plan to generate data on 1500 items and 500 items for the randomized trials, respectively, and on 300 and 800 items from the observational study during the first year (assume no actual data collection). Assume that the proportion of distributed data entry for the two randomized trials is 90% and 30%, respectively, and 100 and 50% for the observational study. Using these assumptions, estimate the minimal base costs associated with providing professional and support staffing, and with the preparations necessary to receive and process data from the four studies during the first year. o Describe the method to be used by the applicant in calculating all operational costs per protocol and per enrolled patient for all Data Center functions. o Describe in general terms a contingency plan to transfer all Data Center functions for one or more active protocols from the incumbent to another Data Center entity which may be successful in the competition. This contingency plan should address the feasibility of transferring specific protocols at various stages of development, including design, enrollment, and analysis. It is anticipated that this transfer will be achieved within six months of the award date. (3b) Research Plan for the Next Competitive Segment for Other (non-incumbent) Applicants o Describe the applicant's perception of its potential role in the Neonatal Network. o Provide a statement of intent to collaborate in a manner consistent with the terms of award. o Propose an operational structure for providing and coordinating all Data Center functions for several Network protocols simultaneously. This should include lines of responsibility/authority for professional staff. o Describe any modifications in the applicant's current processes used to provide Data Center functions that may be made if the applicant were to be selected as the Network Data Center. o Propose an idealized staffing pattern for providing Data Center functions from protocol design through analysis. This should include provisions for adjusting staff time commitments during the life of a study. o Propose an administrative and management structure that would support and enhance the operational structure. o Propose administrative and management functions that would assure continuing attention to cost-efficiency and productivity. This should include adjustment of resource allocation during protocol performance and the potential for outsourcing to improve efficiency or meet short-term needs. o Propose methods to be used to assure effective communication between Data Center staff and other components of the Neonatal Network, including NICHD and the 14 Clinical Centers. o Describe in general terms, a contingency plan to accept all Data Center responsibility and functions for one or more ongoing Network protocol that might be transferred from the incumbent Data Center. This plan should address the feasibility of protocol transfer at various stages of development, including design, enrollment, and analysis. It is anticipated that this transfer will be achieved within six months of the award date. o Assume that three new protocols, including two randomized clinical trials and one observational study, were planned but not yet implemented by the Network Data Center applicant. Assume, however, for this exercise that the three studies plan to collect data on 1500 items and 500 items for the randomized trials, respectively, and on 300 and 800 items from the observational study during the first year (assume no actual data collection). Assume that the proportion of distributed data entry for the two randomized trials is 90% and 30%, respectively, and 100 and 50% for the observational study. Using these assumptions, estimate the minimal base costs associated with providing professional and support staffing, and with the preparations necessary to receive and process data from the four studies during the first year. o Describe the method to be used in calculating all operational costs per protocol and per enrolled patient for all Data Center functions. C. Reference Material Information about protocols, their manual of operations, and about characteristics of the data sets of the several studies will be provided by NICHD staff at an open meeting to be held in Bethesda, Maryland on August 4, 1997. All interested applicants are invited to attend at their own expense. Details about the meeting will be provided by the scientific project officer listed under INQUIRIES. Budget Preparation The instructions for budget requests provided with the Research Grant application form (PHS 398) should be followed. Indirect costs will be awarded in the same manner as for research project grants. Budgets will be reviewed on the basis of appropriateness for the work proposed. Allowable costs and policies governing the research grants programs of the NIH will prevail. In planning the budget section of the application each applicant should submit budget requests for all years. Ongoing annual budgets of the Data Center will consist of base costs (see Appendix I), in addition to protocol-specific capitation fees. At such time as an application has been favorable recommended and is being considered for funding, the Data Center will be required to complete a protocol budget reflecting specific protocol-related costs to be based on the number of patients to be recruited to the protocol and the actual time and effort expended. Capitation awards will be made before implementation and will be revised based on actual recruitment and management costs. Funding for extended analyses will be limited and must be justified on a protocol-by-protocol basis, based on actual time required for analyses. Biostatistical staff with advanced degrees must be justified. Future years' budgets should be limited to base budget costs, with an annual increment not to exceed 3%. SPECIAL REQUIREMENTS - Terms of Agreement The NICHD has established the Neonatal Research Network in order to conduct clinically important research which requires a multicenter setting. The Network consists of 14 Clinical Centers who have agreed to perform common protocols using central data management. Both the Clinical Centers and the Data Center are supported by cooperative agreements, as described below: 1. All components of the Network agree to accept the coordinating role of the group and the collaborative and participatory nature of the Network concept. 2. The management of the Neonatal Research Network includes three committees whose functions are as follows: a. The Steering Committee has primary responsibility for the selection of topics and the design of protocols for Network research (within budget constraints). It is assisted in these functions by the Advisory Board, external reviewers, and the Data Safety and Monitoring Committee. The Steering Committee is also responsible for conduct of the protocols, analysis and interpretation of data, prioritization of Data Center efforts,and the timely preparation of publications. Data ownership resides with the individual Clinical Centers and the Network Steering Committee. The Steering Committee is composed of an independent Chairperson, a Principal Investigator from each of the clinical centers, the Data Center principal investigator, and two NICHD staff. NICHD staff include the Director of the Center for Research for Mothers and Children (CRMC) (non-voting member) and a neonatologist from the Pregnancy and Perinatology Branch (Neonatal Research Network Program Official). The outside chairperson, who is not a principal investigator, is selected by the NICHD, and participates in planning Network activities and overseeing the administrative aspects of the Network in collaboration with the Program Official. A member of the Grants Management Branch advises the Steering Committee on funding matters. b. An Advisory Board advises the NICHD and the Steering Committee in the identification and prioritization of topics for Network research and the preparation of publications. The Advisory Board, chosen by the NICHD is composed of individuals with expertise in clinical trials, biostatistics, epidemiology, perinatology, and neonatology; the Chairpersons of the Neonatal and Maternal Fetal Network Steering Committees; the Program Officials of the Neonatal and Maternal Fetal Networks and the Director of the CRMC; and the Principal Investigator of the Data Centers. c. A Data Safety and Monitoring Committee (DSMC) advises NICHD on research design issues, data quality and analysis, ethical and human subject aspects, and monitors the safety of ongoing clinical trials. It is established by NICHD and its membership represents expertise in clinical trial design and conduct, perinatology, biostatistics, neonatology, basic science, and ethics. The Data Center prepares confidential reports for the DSMC meetings; the Data Center Principal Investigator participates as an ex-officio member and the Deputy Director of the Center for Research for Mothers and Children serves as the Executive Secretary. The Network has established Policies and Procedures that govern its operations, including a publication policy. These documents are under periodic review, and may be amended and supplemented at the discretion of the Steering Committee and NICHD. 3. The Cooperative Agreement funding mechanism is an assistance mechanism. The major difference between a Cooperative Agreement and a research grant is that a Cooperative Agreement specifies substantial programmatic involvement of NICHD staff above and beyond the levels required for traditional program management of grants. The NICHD Neonatal Research Network Program Official will participate in the following ways: o Assistance in the identification ofimportant areas of study. o Assistance in the development of study protocols. o Assistance in the development and review of capitation-based budgets, including the identification of study costs and special institutional needs. o Assistance in the review and evaluation of each stage of the program before subsequent stages are started, in conjunction with the Steering Committee, and the Advisory Board. o Collaborate in analysis and reporting of results to the community of investigators and health care recipients. o Assurance of the scientific merit of the trials. o Assistance in the efficient conduct of the trials. o Monitoring of the data management and quality assurance systems and evaluation of the cost-effectiveness of the Data Center using consultants as appropriate. Criteria will include the quality and quantity of participation in collaborative Network research; timeliness of their efforts; data reports prepared for the Steering Committee and subcommittees; biannual and annual progress reports; and site visit findings. Programmatic responsibility for oversight of these Cooperative Agreements will reside with the Chief, Pregnancy and Perinatology Branch. This role will include the following: o Ongoing review of progress to ensure that objectives are being met; to redirect activities to improve performance and cooperation. o The option to withhold support of a participating clinical center if technical performance requirements such as protocol compliance, enrollment targets, or randomization of subjects are not met. o The option to withhold support from the Data Center if technical performance requirements such as protocol support, data acquisition and analysis targets, and adequate quality assurance of data are not met. 4. The responsibilities and authorities of the awardee will be as follows: o Collaboration in the development, implementation, and monitoring of common protocols. o Data management including preparation of data and safety reports for the Data Safety and Monitoring Committee and preparation of data reports for Network subcommittees, centers, and public data files. o Collaboration in the analysis of data and publication of results of the Neonatal Research Network studies. The specific terms, conditions, and details of arbitration procedures pertaining to the scope and nature of the interaction between NICHD and the participating Neonatal Research Network units and the Data Coordinating Center will be incorporated into the Notice of Grant Award. When agreement between the awardee and the NICHD staff cannot be reached on scientific/programmatic issues that may arise after the award, an arbitration panel will be formed. The panel will consist of one person selected by the principal investigators of the study, one person selected by the NICHD staff and a third selected by these two individuals. The decision of the arbitration panel, by majority vote, will be binding. The special terms of Award of Cooperative Agreement are in addition to, and not in lieu of, otherwise applicable OMB administrative guidelines, DHHS grant administration regulations at 45 CFR Part 74 and other DHHS and NIH grant administration policies. The NICHD review procedure in no way affects the right of a recipient of a cooperative agreement to appeal an adverse determination under the terms of PHS regulations at 42 CFR Part 50, Subpart D, and DHHS regulations at 45 CFR Part 16. Business management aspects of these awards will be administered by the NICHD Grants Management Branch, NICHD, in accordance with DHHS and NIH grants administration requirements. INCLUSION OF WOMEN AND MINORITIES IN RESEARCH INVOLVING HUMAN SUBJECTS It is the policy of the NIH that women and members of minority groups and their subpopulations must be included in all NIH supported biomedical and behavioral research projects involving human subjects, unless a clear and compelling rationale and justification are provided that inclusion is inappropriate with respect to the health of the subjects or the purpose of the research. This policy results from the NIH Revitalization Act of 1993 (Section 492B of Public Law 103-43). All investigators proposing research involving human subjects should read the "NIH Guidelines For Inclusion of Women and Minorities as Subjects in Clinical Research," which have been published in the Federal Register of March 28, 1994 (FR 59-14508-14513) and the NIH Guide for Grants and Contracts, Volume 23, Number 11, March 18, 1994. LETTER OF INTENT Prospective applicants are asked to submit, by August 1, 1997, a letter of intent that includes a descriptive title of the proposed research, the name, address, and telephone number of the Principal Investigator, the identities of other key personnel and participating institutions, and the number and title of the RFA in response to which the application may be submitted. Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information that it contains allows the NICHD staff to estimate the potential review workload and avoid conflict of interest in the review. The letter of intent is to be sent to: Linda L. Wright, M.D. Center for Research for Mothers & Children National Institute of Child Health and Human Development 6100 Executive Boulevard, Room 4B03F - MSC 7510 Bethesda, MD 20892-7510 Telephone: 301-496-5575 Fax: 301-496-3790 Email: lw47i@nih.gov APPLICATION PROCEDURES All applicants must document their ability to meet or exceed the minimum requirements as set out in the SPECIAL REQUIREMENTS section as detailed above. This specifically includes understanding of and commitment to the cooperative nature of this program. Any competing renewal application should include in the progress report a description of how the site has met the special cooperative agreement terms and conditions of the award, including its interaction with other Network sites and the NICHD Program Officer. The research grant application form PHS 398 (rev. 5/95) is to be used in applying for these grants. These forms are available at most institutional offices of sponsored research; from the Office of Extramural Outreach and Information Resources, 6701 Rockledge Drive, MSC 7910, Bethesda, MD 20892; telephone 301-710-0267; e-mail: asknih@odrock.od.nih.gov; and from the program administrator listed under INQUIRIES. The RFA label available in the PHS 398 (rev. 5/95) application form must be affixed to the bottom of the face page of the application. Failure to use this label could result in delayed processing of the application such that it may not reach the review committee in time for review. In addition, the RFA title and number, COOPERATIVE MULTICENTER NEONATAL DATA CENTER RFA HD-97-010, must be typed on line 2 of the face page of the application form and the YES box must be marked. Submit a signed, typewritten original of the application, including the Checklist, and three signed photocopies, in one package to: Division of Research Grants National Institutes of Health 6701 Rockledge Drive, Room 1040 - MSC 7710 Bethesda, MD 20892-7710 Bethesda, MD 20817 (for express/courier service) At the time of submission, two additional copies of the application must be sent to: Division of Scientific Review NIH/NICHD 6100 Building/Room 5E03F 6100 Executive Boulevard, MSC 7510 Bethesda, MD 20892-7510 Applications must be received by September 5, 1997. If an application is received after that date, it will be returned to the applicant without review. The Division of Research Grants (DRG) will not accept any application in response to this RFA that is essentially the same as one currently pending initial review, unless the applicant withdraws the pending application. The DRG will not accept any application that is essentially the same as one already reviewed. This does not preclude the submission of substantial revisions of applications already reviewed, but such applications must include an introduction addressing the previous critique. Schedule Letter of Intent Receipt Date: August 1, 1997 Application Receipt Date: September 19, 1997 NICHD Council Review: January 27, 1998 Earliest Award Date: April 1, 1998 REVIEW CONSIDERATIONS Upon receipt, applications will be reviewed for completeness by DRG and responsiveness by NICHD. Incomplete applications will be returned to the applicant without further consideration. Any application that does not meet the minimum requirements of this RFA will be considered unresponsive to the RFA and returned to the applicant. Applications that are complete and responsive to the RFA will be evaluated for scientific and technical merit by an appropriate peer review group convened by the Division of Scientific Review, NICHD in accordance with the review criteria stated below. As part of the initial merit review, a process may be used by the initial review group in which applications will be determined to be competitive or non-competitive based on their scientific merit relative to other applications received in response to the RFA. Applications determined to be non-competitive will be withdrawn from further consideration and the Principal Investigator and the official signing for the applicant organization will be notified. Those applications that are complete and responsive, will undergo further scientific merit review. The second level of review will be provided by the National Advisory Child Health and Human Development Council. Criteria for Review of Applications: 1. Statistical expertise, qualifications, experience, commitment, and stability of key personnel. o Scientific, organizational, and administrative abilities of the Principal Investigator and other team members; knowledge and experience in areas relevant to the conduct of collaborative clinical research, especially randomized clinical trials, in neonatal medicine and development; availability of the resources necessary to perform as a Data Center. 2. Protocols and Procedures o Quality of the Data Center's participation in either (1) (current Network Data Coordinating Center) Network protocols during the current grant period or (2) (new applicants) multicenter randomized, clinical trials and studies in the recent past; willingness to work cooperatively with the awardees and NICHD in the manner summarized in Terms of Award. 3. Facilities and Management o Efficient organizational structure; quality of administrative, clinical, and data organizational management as described in the minimum requirements; evidence of adequate, cost-effective facilities, including space and equipment for the work proposed, and justification for any new equipment requested under this award; institutional assurance to provide support to the study in such areas as fiscal administration, personnel management, space allocation, procurement, planning and budgeting; 4. Budget o Appropriateness of the proposed budget; evidence of cost-effectiveness; willingness to accept capitation funding as outlined above, including an institutional assurance of cooperation with the policy of capitation of research costs for each individual protocol. 5. Appropriateness of Plans for Protection of Human and Animal Subjects and Compliance with NIH Policy on Inclusion of Women and Minorities. AWARD CRITERIA Applications recommended by the NICHD Council will be considered for award based primarily on scientific and technical merit. Programmatic priorities and availability of funds may also determine the award made. INQUIRIES Inquiries concerning this RFA are encouraged. The opportunity to clarify any issues or questions from potential applicants is welcome. Direct inquiries regarding programmatic issues to: Linda L. Wright, M.D. NIH/NICHD/CRMC/Pregnancy and Perinatology Branch Executive Building/Room 4B03F 6100 Executive Boulevard, MSC 7510 Bethesda, MD 20892-7510 Phone: 301-496-5575 Fax: 301-496-3790 Email: lw47i@nih.gov Direct inquiries regarding fiscal matters to: Ms. Mary Ellen Colvin Grants Management Branch, NIH/NICHD 6100 Building/Room 8A17G 6100 Executive Boulevard MSC 7510 Bethesda, MD 20892-7510 Phone: 301-496-1303 Fax: 301-402-0915 Email: mc113b@nih.gov AUTHORITY AND REGULATIONS This program is described in the Catalog of Federal Domestic Assistance No. 93.3, 93.865. Awards are made under authorization of the Public Health Service Act, Title IV, Part A (Public Law 78-410, as amended by Public Law 99-158, 42 USC 241 and 285) and administered under PHS grants policies and Federal Regulations 42 CFR 52 and 45 CFR Part 74. This program is not subject to the intergovernmental review requirements of Executive Order 12372 or Health Systems Agency review. The PHS strongly encourages all grant and contract recipients to provide a smoke-free workplace and promote the non-use of all tobacco products. In addition, Public Law 103-227, the Pro-Children Act of 1994, prohibits smoking in certain facilities (or in some cases, any portion of a facility) in which regular or routine education, library, day care, health care or early childhood development services are provided to children. This is consistent with the PHS mission to protect and advance the physical and mental health of the American people. Appendix I: At the time of application, the base budget will be required, and a description of a method to calculate operational costs will be required. Base Budget The base budget will be one necessary to design protocols and to prepare to receive data entered from the three hypothetical protocols, and in the research plan outlines for incumbent (3a) and other (3b) applicants, respectively. In addition, other fixed Data Center costs such as supplies and travel may be included, as outlined below: Personnel Principal Investigator >90% Senior biostatistical staff 100% Network coordinator 200% (Liaison between NICHD and Data Center; facilitates communication between Steering Committee members) Secretary 100% Registry (GDB) Statistical staff 25% Technical staff 25% MLS study Statistical staff 100% Technical staff 200% Supplies $ 2,500 Computer systems for 14 Clinical Centers o New distributive data entry systems will be provided to the Clinical Centers Travel - (site visits) $10,000 Capitation budget - (No specific budget requested at time of application) Operational costs are those costs incurred after the start of patient enrollment, based on actual time and effort and resource utilization associated with a specific protocol. They include: o data entry, management, quality control o report generation; data analysis, in addition to that provided by the PI; o arrangement of logistical services; protocol-specific costs, including subcontracts, supplies. The methods to calculate these costs will be used as the basis for individualizing cost recovery for individual protocols. Agreement will be reached by discussions between NICHD staff and the successful applicant. Periodic adjustment of these reimbursement arrangements will be made based on actual experience with individual protocols. .
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |